🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
Status
Completed
Location
Multiple Locations
Start Date
2012-09-10
Trial ID
NCT01682759
Treatments Being Tested
This study will assess the effect of sitagliptin/metformin FDC 50/1000 mg (...
Status
Completed
Location
Multiple Locations
Start Date
2010-05-04
Trial ID
NCT00993187
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
Status
Terminated
Location
Multiple Locations
Start Date
2013-07-08
Trial ID
NCT01863667
Treatments Being Tested
The purpose of this study is to determine the effect of pioglitazone, once ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00770952
Treatments Being Tested
This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-12
Trial ID
NCT02036515
This is a prospective, randomized, active control, two-arm parallel, double...
Status
Terminated
Location
Hannover Medical School, University Eye Hospital and CRC Core Facility Hannover
Start Date
2017-06-12
Trial ID
NCT02985242
Treatments Being Tested
This study will examine the safety and efficacy of the addition of omarigli...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-24
Trial ID
NCT01697592
Treatments Being Tested
A study to compare safety and efficacy of sitagliptin and placebo therapy w...
Status
Completed
Location
Multiple Locations
Start Date
2012-07-09
Trial ID
NCT01590771
Treatments Being Tested
This is a study of co-administration of ertugliflozin (MK-8835/PF-04971729)...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-22
Trial ID
NCT02099110